Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ashish Sharma and Manojit Bhattacharya.
Ashish Sharma
Connection Strength
1.978
Manojit Bhattacharya
  1. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020 11; 85:104587.
    View in: PubMed
    Score: 0.227
  2. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020; 20:100394.
    View in: PubMed
    Score: 0.223
  3. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 06; 92(6):618-631.
    View in: PubMed
    Score: 0.218
  4. The crucial role and regulations of miRNAs in zebrafish development. Protoplasma. 2017 Jan; 254(1):17-31.
    View in: PubMed
    Score: 0.164
  5. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. mBio. 2021 08 31; 12(4):e0114021.
    View in: PubMed
    Score: 0.060
  6. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther. 2021; 27(4):2303-2311.
    View in: PubMed
    Score: 0.060
  7. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021; 12:679344.
    View in: PubMed
    Score: 0.060
  8. SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection. Ann Med Surg (Lond). 2021 Jun; 66:102428.
    View in: PubMed
    Score: 0.059
  9. Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis. Vaccines (Basel). 2021 Jun 04; 9(6).
    View in: PubMed
    Score: 0.059
  10. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2. Infect Genet Evol. 2021 09; 93:104951.
    View in: PubMed
    Score: 0.059
  11. All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently. Aging Dis. 2021 Jun; 12(3):688-690.
    View in: PubMed
    Score: 0.059
  12. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021 Aug; 96:1-4.
    View in: PubMed
    Score: 0.059
  13. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res. 2021 05; 52(4):362-370.
    View in: PubMed
    Score: 0.058
  14. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol. 2021 Feb; 14(2):225-238.
    View in: PubMed
    Score: 0.058
  15. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729.
    View in: PubMed
    Score: 0.058
  16. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic. Immune Netw. 2021 Feb; 21(1):e5.
    View in: PubMed
    Score: 0.058
  17. Response to: Status of Remdesivir: Not Yet Beyond Question! Arch Med Res. 2021 01; 52(1):104-106.
    View in: PubMed
    Score: 0.056
  18. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020; 11:1258.
    View in: PubMed
    Score: 0.056
  19. COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262.
    View in: PubMed
    Score: 0.055
  20. Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak. Arch Med Res. 2020 10; 51(7):728-730.
    View in: PubMed
    Score: 0.055
  21. Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315.
    View in: PubMed
    Score: 0.055
  22. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020 08; 51(6):595-597.
    View in: PubMed
    Score: 0.055
  23. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 08; 51(6):585-586.
    View in: PubMed
    Score: 0.055
  24. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm. 2019 Mar 25; 559:360-372.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.